324 related articles for article (PubMed ID: 9722140)
1. Trinucleotide (CAG) repeat length is positively correlated with the degree of DNA fragmentation in Huntington's disease striatum.
Butterworth NJ; Williams L; Bullock JY; Love DR; Faull RL; Dragunow M
Neuroscience; 1998 Nov; 87(1):49-53. PubMed ID: 9722140
[TBL] [Abstract][Full Text] [Related]
2. Neuropathological diagnosis and CAG repeat expansion in Huntington's disease.
Xuereb JH; MacMillan JC; Snell R; Davies P; Harper PS
J Neurol Neurosurg Psychiatry; 1996 Jan; 60(1):78-81. PubMed ID: 8558157
[TBL] [Abstract][Full Text] [Related]
3. CAG repeat number governs the development rate of pathology in Huntington's disease.
Penney JB; Vonsattel JP; MacDonald ME; Gusella JF; Myers RH
Ann Neurol; 1997 May; 41(5):689-92. PubMed ID: 9153534
[TBL] [Abstract][Full Text] [Related]
4. [Importance of the number of trinucleotide repeat expansions in the clinical manifestations of Huntington's chorea].
Vojvodić N; Culjković B; Romac S; Stojković O; Sternić N; Sokić D; Kostić VS
Srp Arh Celok Lek; 1998; 126(3-4):77-82. PubMed ID: 9863360
[TBL] [Abstract][Full Text] [Related]
5. Expanded CAG trinucleotide repeat of Huntington's disease gene in a patient with schizophrenia and normal striatal histology.
St Clair D
J Med Genet; 1994 Aug; 31(8):658-9. PubMed ID: 7815429
[No Abstract] [Full Text] [Related]
6. Huntington's disease CAG trinucleotide repeats in pathologically confirmed post-mortem brains.
Persichetti F; Srinidhi J; Kanaley L; Ge P; Myers RH; D'Arrigo K; Barnes GT; MacDonald ME; Vonsattel JP; Gusella JF
Neurobiol Dis; 1994 Dec; 1(3):159-66. PubMed ID: 9173995
[TBL] [Abstract][Full Text] [Related]
7. Psychiatric symptoms do not correlate with cognitive decline, motor symptoms, or CAG repeat length in Huntington's disease.
Zappacosta B; Monza D; Meoni C; Austoni L; Soliveri P; Gellera C; Alberti R; Mantero M; Penati G; Caraceni T; Girotti F
Arch Neurol; 1996 Jun; 53(6):493-7. PubMed ID: 8660149
[TBL] [Abstract][Full Text] [Related]
8. Striatal and extrastriatal atrophy in Huntington's disease and its relationship with length of the CAG repeat.
Ruocco HH; Lopes-Cendes I; Li LM; Santos-Silva M; Cendes F
Braz J Med Biol Res; 2006 Aug; 39(8):1129-36. PubMed ID: 16906288
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the CAG repeat number in a patient with Huntington's disease.
Kono Y; Agawa Y; Watanabe Y; Ohama E; Nanba E; Nakashima K
Intern Med; 1999 May; 38(5):407-11. PubMed ID: 10397077
[TBL] [Abstract][Full Text] [Related]
10. A worldwide study of the Huntington's disease mutation. The sensitivity and specificity of measuring CAG repeats.
Kremer B; Goldberg P; Andrew SE; Theilmann J; Telenius H; Zeisler J; Squitieri F; Lin B; Bassett A; Almqvist E
N Engl J Med; 1994 May; 330(20):1401-6. PubMed ID: 8159192
[TBL] [Abstract][Full Text] [Related]
11. Relationship between trinucleotide repeats and neuropathological changes in Huntington's disease.
Furtado S; Suchowersky O; Rewcastle B; Graham L; Klimek ML; Garber A
Ann Neurol; 1996 Jan; 39(1):132-6. PubMed ID: 8572659
[TBL] [Abstract][Full Text] [Related]
12. Expanded CAG repeats in the murine Huntington's disease gene increases neuronal differentiation of embryonic and neural stem cells.
Lorincz MT; Zawistowski VA
Mol Cell Neurosci; 2009 Jan; 40(1):1-13. PubMed ID: 18625318
[TBL] [Abstract][Full Text] [Related]
13. Topography of cerebral atrophy in early Huntington's disease: a voxel based morphometric MRI study.
Kassubek J; Juengling FD; Kioschies T; Henkel K; Karitzky J; Kramer B; Ecker D; Andrich J; Saft C; Kraus P; Aschoff AJ; Ludolph AC; Landwehrmeyer GB
J Neurol Neurosurg Psychiatry; 2004 Feb; 75(2):213-20. PubMed ID: 14742591
[TBL] [Abstract][Full Text] [Related]
14. Striatal volume loss in HD as measured by MRI and the influence of CAG repeat.
Rosas HD; Goodman J; Chen YI; Jenkins BG; Kennedy DN; Makris N; Patti M; Seidman LJ; Beal MF; Koroshetz WJ
Neurology; 2001 Sep; 57(6):1025-8. PubMed ID: 11571328
[TBL] [Abstract][Full Text] [Related]
15. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
Huot P; Lévesque M; Parent A
Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
[TBL] [Abstract][Full Text] [Related]
16. miR-10b-5p expression in Huntington's disease brain relates to age of onset and the extent of striatal involvement.
Hoss AG; Labadorf A; Latourelle JC; Kartha VK; Hadzi TC; Gusella JF; MacDonald ME; Chen JF; Akbarian S; Weng Z; Vonsattel JP; Myers RH
BMC Med Genomics; 2015 Mar; 8():10. PubMed ID: 25889241
[TBL] [Abstract][Full Text] [Related]
17. CAG trinucleotide RNA repeats interact with RNA-binding proteins.
McLaughlin BA; Spencer C; Eberwine J
Am J Hum Genet; 1996 Sep; 59(3):561-9. PubMed ID: 8751857
[TBL] [Abstract][Full Text] [Related]
18. Early alterations in gene expression and cell morphology in a mouse model of Huntington's disease.
Iannicola C; Moreno S; Oliverio S; Nardacci R; Ciofi-Luzzatto A; Piacentini M
J Neurochem; 2000 Aug; 75(2):830-9. PubMed ID: 10899961
[TBL] [Abstract][Full Text] [Related]
19. Molecular analysis of the Huntington's disease gene in New Zealand.
Whitefield JE; Williams L; Snow K; Dixon J; Winship I; Stapleton PM; Faull RM; Love DR
N Z Med J; 1996 Feb; 109(1015):27-30. PubMed ID: 8606810
[TBL] [Abstract][Full Text] [Related]
20. Trinucleotide repeat length and rate of progression of Huntington's disease.
Illarioshkin SN; Igarashi S; Onodera O; Markova ED; Nikolskaya NN; Tanaka H; Chabrashwili TZ; Insarova NG; Endo K; Ivanova-Smolenskaya IA
Ann Neurol; 1994 Oct; 36(4):630-5. PubMed ID: 7944295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
